Edwards Lifesciences Operating Margin 2010-2025 | EW
Current and historical operating margin for Edwards Lifesciences (EW) over the last 10 years. The current operating profit margin for Edwards Lifesciences as of June 30, 2025 is 26.71%.
| Edwards Lifesciences Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $5.69B | $1.47B | 25.86% |
| 2025-03-31 | $5.52B | $1.43B | 25.82% |
| 2024-12-31 | $5.44B | $1.38B | 25.37% |
| 2024-09-30 | $5.07B | $1.36B | 26.81% |
| 2024-06-30 | $4.95B | $1.37B | 27.71% |
| 2024-03-31 | $4.88B | $1.27B | 26.02% |
| 2023-12-31 | $5.01B | $1.31B | 26.12% |
| 2023-09-30 | $4.43B | $1.22B | 27.46% |
| 2023-06-30 | $4.51B | $1.25B | 27.79% |
| 2023-03-31 | $4.58B | $1.45B | 31.60% |
| 2022-12-31 | $4.46B | $1.50B | 33.58% |
| 2022-09-30 | $5.36B | $1.68B | 31.23% |
| 2022-06-30 | $5.36B | $1.66B | 31.06% |
| 2022-03-31 | $5.36B | $1.75B | 32.57% |
| 2021-12-31 | $5.23B | $1.69B | 32.30% |
| 2021-09-30 | $5.10B | $1.67B | 32.72% |
| 2021-06-30 | $4.93B | $1.64B | 33.19% |
| 2021-03-31 | $4.48B | $0.92B | 20.63% |
| 2020-12-31 | $4.39B | $0.90B | 20.45% |
| 2020-09-30 | $4.37B | $0.86B | 19.62% |
| 2020-06-30 | $4.32B | $0.79B | 18.35% |
| 2020-03-31 | $4.48B | $1.23B | 27.45% |
| 2019-12-31 | $4.35B | $1.15B | 26.38% |
| 2019-09-30 | $4.15B | $0.83B | 20.01% |
| 2019-06-30 | $3.97B | $0.79B | 19.82% |
| 2019-03-31 | $3.82B | $0.77B | 20.15% |
| 2018-12-31 | $3.72B | $0.75B | 20.11% |
| 2018-09-30 | $3.64B | $1.06B | 29.13% |
| 2018-06-30 | $3.55B | $1.04B | 29.24% |
| 2018-03-31 | $3.45B | $1.04B | 30.02% |
| 2017-12-31 | $3.44B | $1.09B | 31.74% |
| 2017-09-30 | $3.32B | $0.96B | 28.86% |
| 2017-06-30 | $3.23B | $0.92B | 28.58% |
| 2017-03-31 | $3.15B | $0.89B | 28.25% |
| 2016-12-31 | $2.96B | $0.78B | 26.43% |
| 2016-09-30 | $2.87B | $0.79B | 27.46% |
| 2016-06-30 | $2.74B | $0.75B | 27.27% |
| 2016-03-31 | $2.60B | $0.68B | 26.14% |
| 2015-12-31 | $2.49B | $0.64B | 25.78% |
| 2015-09-30 | $2.44B | $0.62B | 25.32% |
| 2015-06-30 | $2.43B | $0.59B | 24.34% |
| 2015-03-31 | $2.39B | $0.56B | 23.60% |
| 2014-12-31 | $2.32B | $0.49B | 21.23% |
| 2014-09-30 | $2.24B | $0.47B | 21.03% |
| 2014-06-30 | $2.13B | $0.45B | 21.00% |
| 2014-03-31 | $2.07B | $0.46B | 21.97% |
| 2013-12-31 | $2.05B | $0.47B | 23.12% |
| 2013-09-30 | $2.02B | $0.49B | 24.16% |
| 2013-06-30 | $1.97B | $0.48B | 24.19% |
| 2013-03-31 | $1.94B | $0.45B | 23.03% |
| 2012-12-31 | $1.90B | $0.42B | 22.12% |
| 2012-09-30 | $1.82B | $0.36B | 20.01% |
| 2012-06-30 | $1.78B | $0.33B | 18.44% |
| 2012-03-31 | $1.73B | $0.31B | 17.77% |
| 2011-12-31 | $1.68B | $0.30B | 17.87% |
| 2011-09-30 | $1.64B | $0.29B | 17.92% |
| 2011-06-30 | $1.58B | $0.30B | 19.09% |
| 2011-03-31 | $1.51B | $0.30B | 19.85% |
| 2010-12-31 | $1.45B | $0.29B | 19.70% |
| 2010-09-30 | $1.40B | $0.27B | 19.19% |
| 2010-06-30 | $1.38B | $0.26B | 18.78% |
| 2010-03-31 | $1.35B | $0.25B | 18.37% |
| 2009-12-31 | $1.32B | $0.24B | 18.07% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $48.042B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.802B | 22.84 |
| Intuitive Surgical (ISRG) | United States | $170.692B | 70.75 |
| IDEXX Laboratories (IDXX) | United States | $51.647B | 53.75 |
| Alcon (ALC) | Switzerland | $40.456B | 27.16 |
| IQVIA Holdings (IQV) | United States | $32.496B | 18.36 |
| DexCom (DXCM) | United States | $32.259B | 48.39 |
| Mettler-Toledo (MTD) | United States | $27.221B | 32.31 |
| STERIS (STE) | Ireland | $24.807B | 26.40 |
| Waters (WAT) | United States | $17.988B | 24.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.319B | 0.00 |
| Hologic (HOLX) | United States | $15.182B | 16.45 |
| Penumbra (PEN) | United States | $10.325B | 75.42 |
| Globus Medical (GMED) | United States | $8.444B | 19.48 |
| Sysmex ADR (SSMXY) | Japan | $8.410B | 26.72 |
| Masimo (MASI) | United States | $8.074B | 27.17 |
| Teleflex (TFX) | United States | $5.719B | 9.23 |
| Glaukos (GKOS) | United States | $5.400B | 0.00 |
| TransMedics (TMDX) | United States | $4.086B | 62.10 |
| Integer Holdings (ITGR) | United States | $3.874B | 19.33 |
| LivaNova (LIVN) | United Kingdom | $3.052B | 17.47 |
| Veracyte (VCYT) | United States | $2.439B | 33.70 |
| Alphatec Holdings (ATEC) | United States | $2.388B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.294B | 0.00 |
| Artivion (AORT) | United States | $2.115B | 106.74 |
| Elekta AB (EKTAY) | Sweden | $1.924B | 18.00 |
| Nihon Kohden (NHNKY) | Japan | $1.914B | 22.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.158B | 6.63 |
| Pulse Biosciences (PLSE) | United States | $1.147B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| IRadimed (IRMD) | United States | $0.924B | 44.85 |
| Tandem Diabetes Care (TNDM) | United States | $0.806B | 0.00 |
| AxoGen (AXGN) | United States | $0.748B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| SiBone (SIBN) | United States | $0.707B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.543B | 9.60 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.465B | 3.74 |
| Pacific Biosciences Of California (PACB) | United States | $0.415B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.401B | 10.20 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| RxSight (RXST) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.304B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.295B | 20.35 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.268B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.221B | 0.00 |
| Inogen (INGN) | United States | $0.210B | 0.00 |
| CVRx (CVRX) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.125B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.082B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.008B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.54 |